Global Dermatology Drug Market Research Report 2018
Dec, 2018
|
Report ID: 22878
|
110
|
Pharmaceuticals and Healthcare
This report studies the global Dermatology Drug market status and forecast, categorizes the global Dermatology Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
AbbVie (U.S.)
Johnson & Johnson (U.S.)
Bayer (Germany)
Galderma (Switzerland)
Bristol-Myers Squibb (U.S.)
Novartis (China)
Pfizer (U.S.)
Merz Pharma (Germany)
Valeant (Canada)
LEO Pharma (Denmark)
GlaxoSmithKline (UK)
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
External Use
Oral
Injection
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Psoriasis
Skin Infections
Acne
Dermatitis
Other
The study objectives of this report are:
To analyze and study the global Dermatology Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Dermatology Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Dermatology Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Dermatology Drug Manufacturers
Dermatology Drug Distributors/Traders/Wholesalers
Dermatology Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Dermatology Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global Dermatology Drug Market Research Report 2018
1 Dermatology Drug Market Overview
1.1 Product Overview and Scope of Dermatology Drug
1.2 Dermatology Drug Segment by Type (Product Category)
1.2.1 Global Dermatology Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Dermatology Drug Production Market Share by Type (Product Category) in 2017
1.2.3 External Use
1.2.4 Oral
Injection
1.3 Global Dermatology Drug Segment by Application
1.3.1 Dermatology Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Other
1.4 Global Dermatology Drug Market by Region (2013-2025)
1.4.1 Global Dermatology Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Dermatology Drug (2013-2025)
1.5.1 Global Dermatology Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Dermatology Drug Capacity, Production Status and Outlook (2013-2025)
2 Global Dermatology Drug Market Competition by Manufacturers
2.1 Global Dermatology Drug Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Dermatology Drug Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Dermatology Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Dermatology Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Dermatology Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Dermatology Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Dermatology Drug Market Competitive Situation and Trends
2.5.1 Dermatology Drug Market Concentration Rate
2.5.2 Dermatology Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Dermatology Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Dermatology Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Dermatology Drug Production and Market Share by Region (2013-2018)
3.3 Global Dermatology Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Dermatology Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Dermatology Drug Consumption by Region (2013-2018)
4.2 North America Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.4 China Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.5 Japan Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.7 India Dermatology Drug Production, Consumption, Export, Import (2013-2018)
5 Global Dermatology Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Dermatology Drug Production and Market Share by Type (2013-2018)
5.2 Global Dermatology Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Dermatology Drug Price by Type (2013-2018)
5.4 Global Dermatology Drug Production Growth by Type (2013-2018)
6 Global Dermatology Drug Market Analysis by Application
6.1 Global Dermatology Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Dermatology Drug Manufacturers Profiles/Analysis
7.1 AbbVie (U.S.)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Dermatology Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbVie (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson (U.S.)
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Dermatology Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Johnson & Johnson (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bayer (Germany)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Dermatology Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bayer (Germany) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Galderma (Switzerland)
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Dermatology Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Galderma (Switzerland) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb (U.S.)
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Dermatology Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bristol-Myers Squibb (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Novartis (China)
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Dermatology Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Novartis (China) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Pfizer (U.S.)
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Dermatology Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Pfizer (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Merz Pharma (Germany)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Dermatology Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Merz Pharma (Germany) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Valeant (Canada)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Dermatology Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Valeant (Canada) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 LEO Pharma (Denmark)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Dermatology Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 LEO Pharma (Denmark) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 GlaxoSmithKline (UK)
8 Dermatology Drug Manufacturing Cost Analysis
8.1 Dermatology Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Dermatology Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Dermatology Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Dermatology Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Dermatology Drug Market Forecast (2018-2025)
12.1 Global Dermatology Drug Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Dermatology Drug Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Dermatology Drug Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Dermatology Drug Price and Trend Forecast (2018-2025)
12.2 Global Dermatology Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Dermatology Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Dermatology Drug Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Global Dermatology Drug Market Research Report 2018
1 Dermatology Drug Market Overview
1.1 Product Overview and Scope of Dermatology Drug
1.2 Dermatology Drug Segment by Type (Product Category)
1.2.1 Global Dermatology Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Dermatology Drug Production Market Share by Type (Product Category) in 2017
1.2.3 External Use
1.2.4 Oral
Injection
1.3 Global Dermatology Drug Segment by Application
1.3.1 Dermatology Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Other
1.4 Global Dermatology Drug Market by Region (2013-2025)
1.4.1 Global Dermatology Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Dermatology Drug (2013-2025)
1.5.1 Global Dermatology Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Dermatology Drug Capacity, Production Status and Outlook (2013-2025)
2 Global Dermatology Drug Market Competition by Manufacturers
2.1 Global Dermatology Drug Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Dermatology Drug Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Dermatology Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Dermatology Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Dermatology Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Dermatology Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Dermatology Drug Market Competitive Situation and Trends
2.5.1 Dermatology Drug Market Concentration Rate
2.5.2 Dermatology Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Dermatology Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Dermatology Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Dermatology Drug Production and Market Share by Region (2013-2018)
3.3 Global Dermatology Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Dermatology Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Dermatology Drug Consumption by Region (2013-2018)
4.2 North America Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.4 China Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.5 Japan Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Dermatology Drug Production, Consumption, Export, Import (2013-2018)
4.7 India Dermatology Drug Production, Consumption, Export, Import (2013-2018)
5 Global Dermatology Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Dermatology Drug Production and Market Share by Type (2013-2018)
5.2 Global Dermatology Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Dermatology Drug Price by Type (2013-2018)
5.4 Global Dermatology Drug Production Growth by Type (2013-2018)
6 Global Dermatology Drug Market Analysis by Application
6.1 Global Dermatology Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Dermatology Drug Manufacturers Profiles/Analysis
7.1 AbbVie (U.S.)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Dermatology Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbVie (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson (U.S.)
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Dermatology Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Johnson & Johnson (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bayer (Germany)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Dermatology Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bayer (Germany) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Galderma (Switzerland)
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Dermatology Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Galderma (Switzerland) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb (U.S.)
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Dermatology Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bristol-Myers Squibb (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Novartis (China)
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Dermatology Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Novartis (China) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Pfizer (U.S.)
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Dermatology Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Pfizer (U.S.) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Merz Pharma (Germany)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Dermatology Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Merz Pharma (Germany) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Valeant (Canada)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Dermatology Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Valeant (Canada) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 LEO Pharma (Denmark)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Dermatology Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 LEO Pharma (Denmark) Dermatology Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 GlaxoSmithKline (UK)
8 Dermatology Drug Manufacturing Cost Analysis
8.1 Dermatology Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Dermatology Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Dermatology Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Dermatology Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Dermatology Drug Market Forecast (2018-2025)
12.1 Global Dermatology Drug Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Dermatology Drug Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Dermatology Drug Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Dermatology Drug Price and Trend Forecast (2018-2025)
12.2 Global Dermatology Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Dermatology Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Dermatology Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Dermatology Drug Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Dermatology Drug
Figure Global Dermatology Drug Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Dermatology Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of External Use
Table Major Manufacturers of External Use
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Figure Global Dermatology Drug Consumption (K MT) by Applications (2013-2025)
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Dermatology Drug Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2013-2025)
Figure North America Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Dermatology Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Dermatology Drug Capacity, Production (K MT) Status and Outlook (2013-2025)
Figure Global Dermatology Drug Major Players Product Capacity (K MT) (2013-2018)
Table Global Dermatology Drug Capacity (K MT) of Key Manufacturers (2013-2018)
Table Global Dermatology Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Dermatology Drug Capacity (K MT) of Key Manufacturers in 2017
Figure Global Dermatology Drug Capacity (K MT) of Key Manufacturers in 2018
Figure Global Dermatology Drug Major Players Product Production (K MT) (2013-2018)
Table Global Dermatology Drug Production (K MT) of Key Manufacturers (2013-2018)
Table Global Dermatology Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Dermatology Drug Production Share by Manufacturers
Figure 2017 Dermatology Drug Production Share by Manufacturers
Figure Global Dermatology Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Dermatology Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Dermatology Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Dermatology Drug Revenue Share by Manufacturers
Table 2018 Global Dermatology Drug Revenue Share by Manufacturers
Table Global Market Dermatology Drug Average Price (USD/MT) of Key Manufacturers (2013-2018)
Figure Global Market Dermatology Drug Average Price (USD/MT) of Key Manufacturers in 2017
Table Manufacturers Dermatology Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Dermatology Drug Product Category
Figure Dermatology Drug Market Share of Top 3 Manufacturers
Figure Dermatology Drug Market Share of Top 5 Manufacturers
Table Global Dermatology Drug Capacity (K MT) by Region (2013-2018)
Figure Global Dermatology Drug Capacity Market Share by Region (2013-2018)
Figure Global Dermatology Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Capacity Market Share by Region
Table Global Dermatology Drug Production by Region (2013-2018)
Figure Global Dermatology Drug Production (K MT) by Region (2013-2018)
Figure Global Dermatology Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Production Market Share by Region
Table Global Dermatology Drug Revenue (Million USD) by Region (2013-2018)
Table Global Dermatology Drug Revenue Market Share by Region (2013-2018)
Figure Global Dermatology Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Dermatology Drug Revenue Market Share by Region
Figure Global Dermatology Drug Capacity, Production (K MT) and Growth Rate (2013-2018)
Table Global Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table North America Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Europe Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Southeast Asia Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table India Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Global Dermatology Drug Consumption (K MT) Market by Region (2013-2018)
Table Global Dermatology Drug Consumption Market Share by Region (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Consumption (K MT) Market Share by Region
Table North America Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Europe Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table China Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Japan Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Southeast Asia Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table India Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Global Dermatology Drug Production (K MT) by Type (2013-2018)
Table Global Dermatology Drug Production Share by Type (2013-2018)
Figure Production Market Share of Dermatology Drug by Type (2013-2018)
Figure 2017 Production Market Share of Dermatology Drug by Type
Table Global Dermatology Drug Revenue (Million USD) by Type (2013-2018)
Table Global Dermatology Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Dermatology Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Dermatology Drug by Type
Table Global Dermatology Drug Price (USD/MT) by Type (2013-2018)
Figure Global Dermatology Drug Production Growth by Type (2013-2018)
Table Global Dermatology Drug Consumption (K MT) by Application (2013-2018)
Table Global Dermatology Drug Consumption Market Share by Application (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Applications (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Application in 2017
Table Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
Table AbbVie (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Johnson & Johnson (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Bayer (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer (Germany) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer (Germany) Dermatology Drug Production Growth Rate (2013-2018)
Figure Bayer (Germany) Dermatology Drug Production Market Share (2013-2018)
Figure Bayer (Germany) Dermatology Drug Revenue Market Share (2013-2018)
Table Galderma (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galderma (Switzerland) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Production Growth Rate (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Production Market Share (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Novartis (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis (China) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis (China) Dermatology Drug Production Growth Rate (2013-2018)
Figure Novartis (China) Dermatology Drug Production Market Share (2013-2018)
Figure Novartis (China) Dermatology Drug Revenue Market Share (2013-2018)
Table Pfizer (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Merz Pharma (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma (Germany) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Production Growth Rate (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Production Market Share (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Revenue Market Share (2013-2018)
Table Valeant (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant (Canada) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Valeant (Canada) Dermatology Drug Production Growth Rate (2013-2018)
Figure Valeant (Canada) Dermatology Drug Production Market Share (2013-2018)
Figure Valeant (Canada) Dermatology Drug Revenue Market Share (2013-2018)
Table LEO Pharma (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LEO Pharma (Denmark) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Production Growth Rate (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Production Market Share (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Manufacturers in 2017
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure Global Dermatology Drug Capacity, Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Dermatology Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Dermatology Drug Production (K MT) Forecast by Region (2018-2025)
Figure Global Dermatology Drug Production Market Share Forecast by Region (2018-2025)
Table Global Dermatology Drug Consumption (K MT) Forecast by Region (2018-2025)
Figure Global Dermatology Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure North America Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Asia-Pacific Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Europe Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Central & South America Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Central & South America Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Southeast Asia Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure India Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Table Global Dermatology Drug Production (K MT) Forecast by Type (2018-2025)
Figure Global Dermatology Drug Production (K MT) Forecast by Type (2018-2025)
Table Global Dermatology Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Dermatology Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Dermatology Drug Price Forecast by Type (2018-2025)
Table Global Dermatology Drug Consumption (K MT) Forecast by Application (2018-2025)
Figure Global Dermatology Drug Consumption (K MT) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Figure Picture of Dermatology Drug
Figure Global Dermatology Drug Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Dermatology Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of External Use
Table Major Manufacturers of External Use
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Figure Global Dermatology Drug Consumption (K MT) by Applications (2013-2025)
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Dermatology Drug Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2013-2025)
Figure North America Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Dermatology Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Dermatology Drug Capacity, Production (K MT) Status and Outlook (2013-2025)
Figure Global Dermatology Drug Major Players Product Capacity (K MT) (2013-2018)
Table Global Dermatology Drug Capacity (K MT) of Key Manufacturers (2013-2018)
Table Global Dermatology Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Dermatology Drug Capacity (K MT) of Key Manufacturers in 2017
Figure Global Dermatology Drug Capacity (K MT) of Key Manufacturers in 2018
Figure Global Dermatology Drug Major Players Product Production (K MT) (2013-2018)
Table Global Dermatology Drug Production (K MT) of Key Manufacturers (2013-2018)
Table Global Dermatology Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Dermatology Drug Production Share by Manufacturers
Figure 2017 Dermatology Drug Production Share by Manufacturers
Figure Global Dermatology Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Dermatology Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Dermatology Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Dermatology Drug Revenue Share by Manufacturers
Table 2018 Global Dermatology Drug Revenue Share by Manufacturers
Table Global Market Dermatology Drug Average Price (USD/MT) of Key Manufacturers (2013-2018)
Figure Global Market Dermatology Drug Average Price (USD/MT) of Key Manufacturers in 2017
Table Manufacturers Dermatology Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Dermatology Drug Product Category
Figure Dermatology Drug Market Share of Top 3 Manufacturers
Figure Dermatology Drug Market Share of Top 5 Manufacturers
Table Global Dermatology Drug Capacity (K MT) by Region (2013-2018)
Figure Global Dermatology Drug Capacity Market Share by Region (2013-2018)
Figure Global Dermatology Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Capacity Market Share by Region
Table Global Dermatology Drug Production by Region (2013-2018)
Figure Global Dermatology Drug Production (K MT) by Region (2013-2018)
Figure Global Dermatology Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Production Market Share by Region
Table Global Dermatology Drug Revenue (Million USD) by Region (2013-2018)
Table Global Dermatology Drug Revenue Market Share by Region (2013-2018)
Figure Global Dermatology Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Dermatology Drug Revenue Market Share by Region
Figure Global Dermatology Drug Capacity, Production (K MT) and Growth Rate (2013-2018)
Table Global Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table North America Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Europe Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table China Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Japan Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Southeast Asia Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table India Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Table Global Dermatology Drug Consumption (K MT) Market by Region (2013-2018)
Table Global Dermatology Drug Consumption Market Share by Region (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Dermatology Drug Consumption (K MT) Market Share by Region
Table North America Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Europe Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table China Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Japan Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Southeast Asia Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table India Dermatology Drug Production, Consumption, Import & Export (K MT) (2013-2018)
Table Global Dermatology Drug Production (K MT) by Type (2013-2018)
Table Global Dermatology Drug Production Share by Type (2013-2018)
Figure Production Market Share of Dermatology Drug by Type (2013-2018)
Figure 2017 Production Market Share of Dermatology Drug by Type
Table Global Dermatology Drug Revenue (Million USD) by Type (2013-2018)
Table Global Dermatology Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Dermatology Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Dermatology Drug by Type
Table Global Dermatology Drug Price (USD/MT) by Type (2013-2018)
Figure Global Dermatology Drug Production Growth by Type (2013-2018)
Table Global Dermatology Drug Consumption (K MT) by Application (2013-2018)
Table Global Dermatology Drug Consumption Market Share by Application (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Applications (2013-2018)
Figure Global Dermatology Drug Consumption Market Share by Application in 2017
Table Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Dermatology Drug Consumption Growth Rate by Application (2013-2018)
Table AbbVie (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure AbbVie (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Johnson & Johnson (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Johnson & Johnson (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Bayer (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer (Germany) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer (Germany) Dermatology Drug Production Growth Rate (2013-2018)
Figure Bayer (Germany) Dermatology Drug Production Market Share (2013-2018)
Figure Bayer (Germany) Dermatology Drug Revenue Market Share (2013-2018)
Table Galderma (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galderma (Switzerland) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Production Growth Rate (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Production Market Share (2013-2018)
Figure Galderma (Switzerland) Dermatology Drug Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Novartis (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis (China) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis (China) Dermatology Drug Production Growth Rate (2013-2018)
Figure Novartis (China) Dermatology Drug Production Market Share (2013-2018)
Figure Novartis (China) Dermatology Drug Revenue Market Share (2013-2018)
Table Pfizer (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer (U.S.) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Production Growth Rate (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Production Market Share (2013-2018)
Figure Pfizer (U.S.) Dermatology Drug Revenue Market Share (2013-2018)
Table Merz Pharma (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma (Germany) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Production Growth Rate (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Production Market Share (2013-2018)
Figure Merz Pharma (Germany) Dermatology Drug Revenue Market Share (2013-2018)
Table Valeant (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant (Canada) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Valeant (Canada) Dermatology Drug Production Growth Rate (2013-2018)
Figure Valeant (Canada) Dermatology Drug Production Market Share (2013-2018)
Figure Valeant (Canada) Dermatology Drug Revenue Market Share (2013-2018)
Table LEO Pharma (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LEO Pharma (Denmark) Dermatology Drug Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Production Growth Rate (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Production Market Share (2013-2018)
Figure LEO Pharma (Denmark) Dermatology Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Manufacturers in 2017
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure Global Dermatology Drug Capacity, Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Dermatology Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Dermatology Drug Production (K MT) Forecast by Region (2018-2025)
Figure Global Dermatology Drug Production Market Share Forecast by Region (2018-2025)
Table Global Dermatology Drug Consumption (K MT) Forecast by Region (2018-2025)
Figure Global Dermatology Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure North America Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Asia-Pacific Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Europe Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Central & South America Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Central & South America Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure Southeast Asia Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Figure India Dermatology Drug Production (K MT) and Growth Rate Forecast (2018-2025)
Figure India Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Dermatology Drug Production, Consumption, Export and Import (K MT) Forecast (2018-2025)
Table Global Dermatology Drug Production (K MT) Forecast by Type (2018-2025)
Figure Global Dermatology Drug Production (K MT) Forecast by Type (2018-2025)
Table Global Dermatology Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Dermatology Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Dermatology Drug Price Forecast by Type (2018-2025)
Table Global Dermatology Drug Consumption (K MT) Forecast by Application (2018-2025)
Figure Global Dermatology Drug Consumption (K MT) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
